To me it seems whatever the shortcomings with plant development...

To me it seems whatever the shortcomings with plant development and operations they have timed the financing well especially the most recent rights issue. Given that I think the re-financing will go well.
I don't necessarily attribute full credit to MDL's executives but a significant input form Eramet. (Which is the benefit of a big brother).